What to Expect from Kimberly-Clark's Earnings

Kimberly-Clark KMB is preparing to release its quarterly earnings on Tuesday, 2024-10-22. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Kimberly-Clark to report an earnings per share (EPS) of $1.70.

The announcement from Kimberly-Clark is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Historical Earnings Performance

The company's EPS beat by $0.25 in the last quarter, leading to a 3.41% increase in the share price on the following day.

Here's a look at Kimberly-Clark's past performance and the resulting price change:

Quarter Q2 2024 Q1 2024 Q4 2023 Q3 2023
EPS Estimate 1.71 1.63 1.54 1.59
EPS Actual 1.96 2.01 1.51 1.74
Price Change % 3.0% 1.0% 2.0% -1.0%

eps graph

Tracking Kimberly-Clark's Stock Performance

Shares of Kimberly-Clark were trading at $145.41 as of October 18. Over the last 52-week period, shares are up 19.84%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Observations about Kimberly-Clark

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Kimberly-Clark.

The consensus rating for Kimberly-Clark is Neutral, based on 7 analyst ratings. With an average one-year price target of $147.86, there's a potential 1.68% upside.

Peer Ratings Comparison

This comparison focuses on the analyst ratings and average 1-year price targets of Church & Dwight Co, Clorox and Colgate-Palmolive, three major players in the industry, shedding light on their relative performance expectations and market positioning.

  • Church & Dwight Co received a Underperform consensus from analysts, with an average 1-year price target of $103.58, implying a potential 28.77% downside.
  • The prevailing sentiment among analysts is an Neutral trajectory for Clorox, with an average 1-year price target of $152.42, implying a potential 4.82% upside.
  • The prevailing sentiment among analysts is an Buy trajectory for Colgate-Palmolive, with an average 1-year price target of $108.58, implying a potential 25.33% downside.

Key Findings: Peer Analysis Summary

The peer analysis summary offers a detailed examination of key metrics for Church & Dwight Co, Clorox and Colgate-Palmolive, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

Company Consensus Revenue Growth Gross Profit Return on Equity
Kimberly-Clark Neutral -2.05% $1.81B 49.91%
Church & Dwight Co Underperform 3.92% $712.10M 5.79%
Clorox Neutral -5.75% $884M 103.10%
Colgate-Palmolive Buy 4.89% $3.07B 414.16%

Key Takeaway:

Kimberly-Clark ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, Kimberly-Clark is at the top.

Discovering Kimberly-Clark: A Closer Look

With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Financial Insights: Kimberly-Clark

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Decline in Revenue: Over the 3 months period, Kimberly-Clark faced challenges, resulting in a decline of approximately -2.05% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.

Net Margin: Kimberly-Clark's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.82% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Kimberly-Clark's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 49.91%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): Kimberly-Clark's ROA stands out, surpassing industry averages. With an impressive ROA of 3.17%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Kimberly-Clark's debt-to-equity ratio is below the industry average. With a ratio of 7.01, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

To track all earnings releases for Kimberly-Clark visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!